[ Back to EurekAlert! ]

Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine

Jeffrey M. Arbeit and David T. Curiel, Washington University School of Medicine

Caption: Embargoed until 5 p.m. ET Monday, Dec. 23, 2013. Working in mice, researchers at Washington University School of Medicine in St. Louis report developing a gene delivery method long sought in the field of gene therapy: a deactivated virus carrying a gene of interest that can be injected into the bloodstream and make its way to the right cells. Jeffrey M. Arbeit, MD, (left) and David T. Curiel, MD, PhD, and their colleagues designed a viral vector that homes in on the abnormal blood vessels of tumors, opening up new therapeutic possibilities for gene therapy against cancer and other conditions that involve abnormal vasculature.

Credit: Robert J. Boston

Usage Restrictions: None

Related news release: Gene therapy method targets tumor blood vessels


[ Back to EurekAlert! ]